Lactamase amplification substrate
View Patent ↗An amplifiable β-lactamase substrate is provided comprising an enzyme donor fragment of β-galactosidase linked to form a ring to a β-lactam ring that is a substrate for lactamase and upon opening of the β-lactam ring the enzyme donor fragment becomes linearized. The cyclic substrate only weakly binds to the enzyme acceptor fragment of β-galactosidase. The substrate finds application for the sensitive detection of β-lactamase for direct detection of the enzyme or when the enzyme is used as a label.
1. A cyclic lactamase substrate comprising an enzyme donor fragment of β-galactosidase joined on opposite sides of a β-lactam ring, wherein upon hydrolysis of said lactam ring, the activity of said enzyme donor fragment of β-galactosidase in complexing with the enzyme acceptor fragment of β-galactosidase is increased at least 10-fold.
2. A cyclic lactamase substrate according to claim 1 , wherein said β-lactam ring is part of a cephalosporin molecule.
3. A cyclic lactamase substrate according to claim 2 , wherein said enzyme donor fragment has a sequence of from 35 to 90 amino acids of said β-galactosidase.
4. A cyclic lactamase substrate according to claim 1 , wherein said enzyme donor fragment includes a cysteine proximal to each terminus and is joined to said β-lactam ring through thio ethers.
5. A cyclic lactamase substrate of the formula:
wherein:
E D is an enzyme donor sequence of β-galactosidase having reactive functional groups extending from the sequence and not more than weakly capable of complexing with the enzyme acceptor fragment of β-galactosidase and capable of strongly complexing with the enzyme acceptor fragment of β-galactosidase upon linearization:
the two L's are the linking groups, which may be the same or different and are a bond or a linking group of from 1 to 20 atoms in the chain;
the two F's are the same or different and are the functional groups resulting from the linking of the Fs to the β-lactam moiety; and
BL is the β-lactam moiety
wherein upon cleavage of the β-lactam moiety, F is released resulting in linearization of the cyclic lactamase substrate.
6. A cyclic lactamase substrate according to claim 5 , wherein said BL is a cephalosporin linked at the methylene group at the 3 position to F.
7. A cyclic lactamase substrate according to claim 5 , wherein said Ls have individually at least one of a carbonyl group or thioether group.
8. A cyclic lactamase substrate of the formula:
wherein:
E D is an enzyme donor sequence of β-galactosidase having reactive functional groups extending from the sequence and not more than weakly capable of complexing with the enzyme acceptor fragment of β-galactosidase and capable of strongly complexing with the enzyme acceptor fragment of β-galactosidase upon linearization;
Ls are a bond or linking group of from 1 to 16 carbon atoms;
the two Fs are formed by joining to L through a mercaptan or amine; and
BL is the β-lactam moiety.
9. A cyclic lactamase substrate according to claim 8 , wherein said Fs are linked through a mercaptan to an activated olefin, halide, pseudohalide, isothiocyanate, or S-pyridyl.
10. A cyclic lactamase substrate according to claim 9 , wherein said Fs are linked through a mercaptan by the compound
and BL is a cephalosporin moiety.
11. A cyclic lactamase substrate according to claim 10 , wherein said Ls are a bond and said ED terminates with a cysteine at each terminus.
12. A cyclic lactamase substrate according to claim 8 , wherein said Fs are linked through an amine to an N-hydroxy succinimide ester, imidate ester isocyanate, isothiocyanate, or activated halogen.